Everolimus may play a role in ACC, as, in an ACC cell line, Younes et al.40 showed the role of phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) as potentially target of therapy. The gene discussed is MTOR; the disease is adrenal cortex carcinoma.